---
layout: minimal-medicine
title: Agalsidase Beta
---

# Agalsidase Beta
### Generic Name
Agalsidase Beta

### Usage
Agalsidase beta is a medication used to treat Fabry disease.  Fabry disease is a rare, inherited disorder caused by a deficiency of the enzyme alpha-galactosidase A. This enzyme deficiency leads to a buildup of globotriaosylceramide (GL-3), a fatty substance, in various organs and tissues throughout the body. This accumulation can damage the kidneys, heart, blood vessels, and nervous system, leading to a range of symptoms and complications. Agalsidase beta works by replacing the missing or deficient enzyme, helping to break down the GL-3 and reduce its buildup.  This helps to manage the disease's progression and alleviate some of its symptoms.


### Dosage
The dosage of agalsidase beta is administered intravenously (IV) and is determined by a healthcare professional based on individual patient needs.

**Adults with Fabry Disease:** The typical dose is 1 mg/kg of body weight given as an IV infusion every two weeks.  The initial infusion rate should be slow, generally not exceeding 0.25 mg/minute for patients weighing less than 30 kg, and the infusion should be given over at least 1.5 hours for those weighing 30 kg or more.  The healthcare provider may adjust the infusion rate based on the patient's tolerance.

**Children (â‰¥8 years) with Fabry Disease:** The dosage is the same as for adults (1 mg/kg every two weeks).  Infusion rate adjustments are also made based on individual tolerance.


**Dosage Adjustments:**  The manufacturer's labeling does not currently specify dosage adjustments for patients with hepatic (liver) or renal (kidney) impairment. However,  patients with a history of allergic reactions to agalsidase beta may require a significantly lower initial dose and a gradual increase as tolerated.  A healthcare professional will carefully monitor and adjust the dosage as needed.


### Side Effects

**Common Side Effects (occurring in more than 10% of patients):**

*   Chills
*   Headache
*   Paresthesia (numbness or tingling)
*   Fatigue
*   Dizziness
*   Pain
*   Sensation of cold
*   Peripheral edema (swelling)
*   Hypertension (high blood pressure)
*   Skin rash
*   Infusion site reactions (reactions at the site where the infusion is given)
*   Fever
*   Upper respiratory tract infections
*   Cough
*   Nasal congestion
*   Muscle pain (myalgia)
*   Back pain
*   Limb pain


**Less Common but Serious Side Effects (occurring in less than 10% of patients, or reported in post-marketing surveillance):**

*   Anaphylaxis (severe allergic reaction)
*   Hypersensitivity reactions
*   Cardiac arrhythmias
*   Low cardiac output
*   Respiratory failure
*   Cardiac failure
*   Sepsis (life-threatening infection)
*   Stroke
*   Myocardial infarction (heart attack)
*   Renal failure
*   Pneumonia


It's crucial to report any adverse effects to a healthcare provider immediately.


### How it Works
Agalsidase beta is a replacement enzyme therapy.  In individuals with Fabry disease, the body lacks or has insufficient alpha-galactosidase A, an enzyme vital for breaking down certain fatty substances (glycosphingolipids) in cells. This leads to the accumulation of these substances, particularly GL-3.  Agalsidase beta is a manufactured version of this missing enzyme.  When administered intravenously, it enters the bloodstream and acts as a substitute for the naturally occurring enzyme. It helps break down and remove the accumulated GL-3 from cells and tissues, thereby reducing the buildup and mitigating the harmful effects of the disease.


### Precautions

*   **Contraindication:** Agalsidase beta is contraindicated in patients who have experienced anaphylaxis (a severe, life-threatening allergic reaction) to agalsidase beta or any of its components.
*   **Allergies:** Patients with a history of severe allergic reactions should be carefully monitored during administration.
*   **Cardiac Function:** Use caution in patients with compromised cardiac function.
*   **Infusion Reactions:** Patients with a history of infusion reactions should be closely monitored.  Pre-medication with antipyretics (fever reducers) and antihistamines may be considered.
*   **Antibody Formation:**  The development of antibodies against agalsidase beta can occur, potentially reducing the drug's effectiveness. Monitoring for antibody formation is important.
*   **Pregnancy and Breastfeeding:** Agalsidase beta is categorized as pregnancy category B.  While it's not expected to cause harm to the fetus, it should be used with caution during pregnancy. It's also excreted in breast milk, so caution is advised during breastfeeding.  A healthcare professional should be consulted to assess the risks and benefits.
*   **Drug Interactions:**  Some medications, such as amiodarone, chloroquine, and systemic gentamicin, may interact with agalsidase beta and reduce its effectiveness.  The use of these medications should be discussed with a healthcare professional.


### FAQs

*   **Q: How is agalsidase beta administered?**  A: It is administered intravenously (IV) by a healthcare professional.

*   **Q: How long does it take to see results?** A: The effects of agalsidase beta vary, and improvements may be gradual.  Regular monitoring and clinical evaluations are necessary to assess response.

*   **Q: What should I do if I experience side effects?** A: Report any side effects to your healthcare provider immediately.  Some side effects can be serious and require medical attention.

*   **Q: How should agalsidase beta be stored?** A:  Refer to the specific storage instructions provided by your pharmacist or on the medication packaging. Generally, refrigeration is necessary.

*   **Q: Is agalsidase beta suitable for children?** A:  Yes, it is used to treat Fabry disease in children aged 8 years and older, with dosage adjusted based on weight.

*   **Q: Can agalsidase beta cure Fabry disease?** A:  No, it is not a cure. It is a replacement therapy that helps manage the disease and reduce its symptoms and complications.  It aims to slow the progression of the disease, not reverse it.

**Disclaimer:** *This information is for general knowledge and does not constitute medical advice.  Always consult with a healthcare professional for diagnosis and treatment of any medical condition.  The specific details of dosage, administration, and potential side effects may vary depending on the manufacturer and the individual patient's circumstances.*
